OPRYMEA 0.7mg tablets KRKA
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
letter O · page 27
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
pramipexole Indicated for: Parkinson's disease
N04BC05 Nervous system | Dopaminergic agents | Dopamine agonists
macitentan Indicated for: pulmonary arterial hypertension
macitentan Indicated for: pulmonary arterial hypertension
flu vaccine Indicated for: prevention of influenza
J07BB02 Antiinfectives for systemic use | Viral vaccines | Influenza vaccines
combinations Indicated for: various therapeutic indications
A11AA03 Alimentary tract and metabolism | Multivitamins, combinations | Multivitamins with minerals
combinations Indicated for: various therapeutic indications
A11AA02 Alimentary tract and metabolism | Multivitamins, combinations | Multivitamins with minerals
normal immunoglobulin for intravascular administration Indicated for: immunosuppression
J06BA02 Antiinfectives for systemic use | Immunoglobulins | Immunoglobulins, normal human
dorzolamide + timolol Indicated for: glaucoma; ocular hypertension
S01ED51 Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents
brinzolamide Indicated for: glaucoma; ocular hypertension
S01EC04 Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors
gadoversetamide Indicated for: diagnostic imaging contrast enhancement
V08CA06 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
gadoversetamide Indicated for: diagnostic imaging contrast enhancement
V08CA06 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
gadoversetamide Indicated for: diagnostic imaging contrast enhancement
V08CA06 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
gadoversetamide Indicated for: diagnostic imaging contrast enhancement
V08CA06 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media
gadoversetamide Indicated for: diagnostic imaging contrast enhancement
V08CA06 Various | Magnetic resonance imaging contrast media | Paramagnetic contrast media